Related Blog Posts
Diabetic Cure
3 hours ago ago from Diabetic Meal Plans Free!
Many people were cured, and thus the FDA and large pharmaceutical companies were losing money on not being able to dispense conventional medicine as they pleased and therefore these clinics were gaining popularity over the larger government hospitals approved by the FDA. Many insurance companies and the end user - the patient. The safest and most reliable source for obtaining a generic drug is through a local pharmacy or an approved online ...
Related contentCan Tamper Evidence Reduce Risk?
8 hours ago ago from Pharmaceutical & Medical Packaging News Insider
Recent cases of syringe tampering has made me wonder: should prefilled syringes carry tamper evidence as part of a risk-mitigation strategy? Tamper-evident packaging is not required for prescription drugs. According to an FDA spokesperson, the regulation that requires tamper-evident packaging (21 CFR 211.132) applies only to over-the-counter drugs, not prescription drugs. Explained another: The intent of tamper-evident packaging ...
Related contentWhat is Involved in Drug Addiction Treatment?
13 hours ago ago from Addiction Treatment
Drug addiction is a condition that is characterized by an uncontrollable and compulsive drug. It is a complex and chronic disease that can take over your life and make it difficult to concentrate on other aspects. It is a pathological condition that is described in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). It has been shown that prolonged drug use has a negative effect works on the brain. ...
Related contentU.S. versus Solvay Pharmaceuticals, Inc. Dismissed by US Court of Appeals
17 hours ago ago from Policy and Medicine
The U.S. Court of Appeals for the Eleventh Circuit this week issued a decision that restricts the use of the federal False Claims Act (FCA) as a tool for suppressing truthful speech about off-label uses of medical products approved by the Food and Drug Administration (FDA). The court’s dismissal of the case U.S.ex rel Hopper v. Solvay Pharmaceuticals, Inc. was a victory for the Washington Legal Foundation (WLF), which had filed a ...
Related contentWhat You Should Know About Getting Started with Homeopathy
3 hours ago ago from Moomette's Magnificents
Home Treatments Homeopathy is an alternative form of medicine that has been used for thousands of years to treat everything from life threatening illnesses to the common cold. While many people used to modern medicine may find it suspicious, it is still one of the most used types of medical treatment worldwide and is steadily gaining popularity in the western world. Homeopathic medicine is based on three basic principles. The ...
Related contentRelated News
Two Arrested For Drugs In Aiken
7 hours ago ago from Media General - WJBF.com
Search: Keyword Site Web | RSS + - Text Size Print Share This Two Arrested For Drugs In Aiken Next Image Previous Image mug shot of Deon Lee Simpkins Aiken Department of Public Safety According to Sgt. Aaron Dowdy, the Aiken Department of Public Safety (ADPS) has ...
Related contentFDA confirms benefits of Crestor in more patients
16 hours ago ago from PopEater
WASHINGTON -Federal scientists say AstraZeneca's cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain. The Food and Drug Administration has confirmed the findings of a AstraZeneca study released last November. The study showed that patients with lower cholesterol and few heart risks could still benefit from taking Crestor, setting the ...
Related contentNew Novartis Leukemia Drug Beats Gleevec in Trial
7 hours ago ago from Wall Street Journal
Novartis AG's new leukemia drug, Tasigna, performed better than the company's blockbuster Gleevec leukemia treatment in initial results of a clinical trial, a finding that could help Novartis start positioning the newer drug to replace Gleevec. Gleevec is the company's second biggest selling drug, with revenue of $3.7 billion last year. But it will lose patent protection and face competition from low-cost generic copies in 2015. If enough ...
Related content
